282 related articles for article (PubMed ID: 27554081)
21. BRAF inhibition in hairy cell leukemia with low-dose vemurafenib.
Dietrich S; Pircher A; Endris V; Peyrade F; Wendtner CM; Follows GA; Hüllein J; Jethwa A; Ellert E; Walther T; Liu X; Dyer MJ; Elter T; Brummer T; Zeiser R; Hermann M; Herold M; Weichert W; Dearden C; Haferlach T; Seiffert M; Hallek M; von Kalle C; Ho AD; Gaehler A; Andrulis M; Steurer M; Zenz T
Blood; 2016 Jun; 127(23):2847-55. PubMed ID: 26941398
[TBL] [Abstract][Full Text] [Related]
22. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
[TBL] [Abstract][Full Text] [Related]
23. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract][Full Text] [Related]
24. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
Acquaviva J; Smith DL; Jimenez JP; Zhang C; Sequeira M; He S; Sang J; Bates RC; Proia DA
Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
[TBL] [Abstract][Full Text] [Related]
25. The utility of BRAF V600E mutation-specific antibody VE1 for the diagnosis of hairy cell leukemia.
Uppal G; Ly V; Wang ZX; Bajaj R; Solomides CC; Banks PM; Medeiros LJ; Peiper SC; Gong JZ
Am J Clin Pathol; 2015 Jan; 143(1):120-5. PubMed ID: 25511150
[TBL] [Abstract][Full Text] [Related]
26. Novel therapeutic options for relapsed hairy cell leukemia.
Jain P; Polliack A; Ravandi F
Leuk Lymphoma; 2015; 56(8):2264-72. PubMed ID: 25563425
[TBL] [Abstract][Full Text] [Related]
27. ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.
Cesi G; Walbrecq G; Zimmer A; Kreis S; Haan C
Mol Cancer; 2017 Jun; 16(1):102. PubMed ID: 28595656
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay.
Verma S; Greaves WO; Ravandi F; Reddy N; Bueso-Ramos CE; O'Brien S; Thomas DA; Kantarjian H; Medeiros LJ; Luthra R; Patel KP
Am J Clin Pathol; 2012 Jul; 138(1):153-6. PubMed ID: 22706871
[TBL] [Abstract][Full Text] [Related]
29. Biology and Treatment of Hairy Cell Leukemia.
Paillassa J; Troussard X
Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
[TBL] [Abstract][Full Text] [Related]
30. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
Paillassa J; Maitre E; Troussard X
Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
[TBL] [Abstract][Full Text] [Related]
31. How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors.
Falini B; De Carolis L; Tiacci E
Blood; 2022 Apr; 139(15):2294-2305. PubMed ID: 35143639
[TBL] [Abstract][Full Text] [Related]
32. Hairy Cell Leukaemia.
Cross M; Dearden C
Curr Oncol Rep; 2020 Apr; 22(5):42. PubMed ID: 32297104
[TBL] [Abstract][Full Text] [Related]
33. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias.
Tschernitz S; Flossbach L; Bonengel M; Roth S; Rosenwald A; Geissinger E
Br J Haematol; 2014 May; 165(4):529-33. PubMed ID: 24433452
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
Langabeer SE; O'Brien D; Liptrot S; Flynn CM; Hayden PJ; Conneally E; Browne PV; Vandenberghe E
Int J Lab Hematol; 2012 Aug; 34(4):417-21. PubMed ID: 22313586
[TBL] [Abstract][Full Text] [Related]
35. New insights in the management of patients with hairy cell leukemia.
Cornet E; Damaj G; Troussard X
Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
[TBL] [Abstract][Full Text] [Related]
36. V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia.
Arora N; Nair S; Pai R; Nair S; Ahmed R; Abraham A; Viswabandya A; George B; Balasubramanian P; Srivastava A; Mathews V
Indian J Pathol Microbiol; 2015; 58(1):62-5. PubMed ID: 25673595
[TBL] [Abstract][Full Text] [Related]
37. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
38. Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
Maitre E; Paillassa J; Troussard X
Front Oncol; 2022; 12():1068981. PubMed ID: 36620555
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
Brown NA; Betz BL; Weigelin HC; Elenitoba-Johnson KS; Lim MS; Bailey NG
Am J Clin Pathol; 2015 Jan; 143(1):89-99. PubMed ID: 25511147
[TBL] [Abstract][Full Text] [Related]
40. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
